Job title: Co-Founder & CEO
Lorenzo Corsini is a biotech and consulting professional, at PhagoMed as Co-Founder, CEO, Research & Development since it was founded in November 2017. Lorenzo was involved in successfully raising €4m from private and governmental investors to develop PhagoMed’s assets. At PhagoMed, Lorenzo designed the R&D program and leads, motivates, develops, and coaches a team of 4 in PhagoMed’s internal lab and manages 4 research contracts with academic and CRO partners. As a Principal at BCG until 2017, Lorenzo lead multiple teams on projects in pharma manufacturing, R&D, pharmacovigilance and other areas. Lorenzo brings in the analytical and structured thinking of a biochemist, and the communication and interpersonal skills developed while working across levels (board members to shopfloor workers) and functions at multiple leading Pharma and Generics companies.
Panel Discussion: Understanding the Strategies to Take Bacteriophage-Based Products to Market 3:30 pm
day: Day One
Precision Biofilm Disruption and Vaginome Editing with Phage-Based Drug Candidates 2:30 pm
day: Day Two